Management of infection in patients with acute leukemia during chemotherapy in Japan: Questionnaire analysis by the Japan adult leukemia study group

International Journal of Hematology

Volumn 90, Issue 2, 2009, Pages 191-198

  Fujita, Hiroyuki ^a,b   Yoshida, Minoru ^b   Miura, Katsuhiro ^b   Sano, Tetsuaki ^b   Kito, Katsuyuki ^b   Takahashi, Masatomo ^b   Shigeno, Kazuyuki ^b   Kanda, Yoshinobu ^b   Akiyama, Nobu ^b   Hatsumi, Naoko ^b   Ohnishi, Kazunori ^b   Miyawaki, Shuichi ^b   Naoe, Tomoki ^b  

^a YOKOHAMA CITY UNIVERSITY HOSPITAL   (Japan)

^b Japan Adult Leukemia Study Group   (Japan)

Author keywords

Febrile neutropenia; G CSF; JALSG; Leukemia; Prophylaxis

Indexed keywords

AMINOGLYCOSIDE; AMPHOTERICIN B; CARBAPENEM; CEPHEM; COTRIMOXAZOLE; FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; ITRACONAZOLE; MICAFUNGIN; PENICILLIN G; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULFAMETHOXAZOLE; TRIMETHOPRIM; VANCOMYCIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; CANCER CHEMOTHERAPY; CONTROLLED STUDY; FEBRILE NEUTROPENIA; FOLLOW UP; HEALTH SURVEY; HUMAN; JAPAN; MONOTHERAPY; MYCOSIS;

ACUTE DISEASE; ADULT; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIAL INFECTIONS; DRUG THERAPY, COMBINATION; FEVER; GRANULOCYTE COLONY-STIMULATING FACTOR; HEALTH CARE SURVEYS; HUMANS; JAPAN; LEUKEMIA; MYCOSES; NEUTROPENIA; QUESTIONNAIRES;

EID: 70350566653     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12185-009-0367-5     Document Type: Article

References (12)

1. T Masaoka 1998 Evidence-based recommendations on antimicrobial use in febrile neutropenia in Japan Int J Hematol 68 Suppl 1 1 40
2. T Masaoka 2004 Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: executive summary Clin Infect Dis 39 Suppl 1 S49 S52 15250021 10.1086/383054 (Pubitemid 38971476)
3. M Yoshida N Akiyama M Takahashi H Taguchi J Takeuchi K Naito, et al. 2003 Management of infectious complications in patients with acute leukemia during chemotherapy: a questionnaire analysis by the Japan Adult Leukemia Study Group Jpn J Chemother 51 703 710
4. M Yoshida R Ohno 2004 Current antimicrobial usage for the management of infections in leukemic patients in Japan: results of a survey Clin Infect Dis 39 Suppl 1 S11 S14 15250015 10.1086/383044 (Pubitemid 38971470)
5. WT Hughes D Armstrong GP Bodey EJ Bow AE Brown T Calandra, et al. 2002 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer Clin Infect Dis 34 730 751 11850858 10.1086/339215 (Pubitemid 34194843)
6. A Gafter-Gvili A Fraser M Paul L Leibovici 2005 Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients Ann Intern Med 142 979 995 15968013
7. G Bucaneve A Micozzi F Menichetti P Martino MS Dionisi G Martinelli, et al. 2005 Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia N Engl J Med 353 977 987 16148283 10.1056/NEJMoa044097 1:CAS:528:DC%2BD2MXpvVOis7k%3D (Pubitemid 41262332)
8. E Robenshtok A Gafter-Gvili M Weinberger M Yeshurun L Leibovici M Paul 2007 Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis J Clin Oncol 25 5471 5489 17909198 10.1200/JCO.2007.12.3851 1:CAS:528: DC%2BD1cXnvVChsQ%3D%3D (Pubitemid 350232225)
9. PA Pizzo JW Hathorn J Hiemenz M Browne J Commers D Cotton, et al. 1986 A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia N Engl J Med 315 552 558 3526155 1:STN:280:DyaL283osV2juw%3D%3D
10. K Tamura K Imajo N Akiyama K Suzuki A Urabe K Ohyashiki, et al. 2004 Randomized trial of cefepime monotherapy or cefepime in combination with amikacin as empirical therapy for febrile neutropenia Clin Infect Dis 39 Suppl 1 S15 S24 15250016 10.1086/383046 1:CAS:528:DC%2BD2cXntVahs78%3D (Pubitemid 38971471)
11. R Herbrecht DW Denning TF Patterson JE Bennett RE Greene JW Oestmann, et al. 2002 Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis N Engl J Med 347 408 415 12167683 10.1056/NEJMoa020191 1:CAS:528:DC%2BD38XlvFKrt7o%3D (Pubitemid 34851833)
12. TJ Smith J Khatcheressian GH Lyman H Ozer JO Armitage L Balducci, et al. 2006 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline J Clin Oncol 24 19 3187 3205 16682719 10.1200/JCO.2006.06.4451 1:CAS:528:DC%2BD28XnslKhsLo%3D (Pubitemid 46638957)